Bluup Injection

Adult administration

Used according to the doctor's prescription, ensuring to adjust the dosage based on plasma trace element levels. - Patients receiving stable non-oral nutrition solution: Zinc: 2.5 to 4 mg per day Copper: 0.5 to 1.5 mg per day Manganese: 0.15 to 0.8 mg per day Chromium: 10 to 15μg per day Selenium: 20 to 40μg per day - Others Acute burn patients: 4.5 to 6 mg per day Patients with stable intestinal fluid loss: 1 day

Child administration

Pediatric patients - Under 5 years: Zinc: 100μg per kg body weight per day Copper: 20μg per kg body weight per day Manganese: 2 to 10μg per kg body weight per day Chromium: 0.14 to 0.20μg per kg body weight per day Selenium: 1

This medication should not be used in premature infants and neonates due to the inclusion of benzyl alcohol, which can cause fatal respiratory problems in this age group. Direct intravenous injection of this medication without dilution may induce phlebitis, so it must be used after dilution. Additionally, it is a hypotonic solution and should only be used when injected mixed with other medications. Although the trace elements included in this medication do not exhibit toxicity at usual doses, if signs of toxicity occur during administration, treatment should be discontinued immediately. The physician must accurately assess the patient's condition and the required metabolic load before administration, and the blood levels of trace elements should be frequently monitored to adjust the dosage. Caution is required in patients with impaired renal function or biliary obstruction, as the excretion of certain trace elements may be compromised, leading to accumulation in the body. The safety of this medication during pregnancy or in women of childbearing potential has not been sufficiently established; therefore, it should only be used when the benefits of treatment outweigh the risks. In cases of overdose, toxic symptoms may arise from zinc, copper, chromium, and selenium, necessitating immediate appropriate measures. This medication should not be used without a doctor's prescription, and when added to non-oral nutritional solutions, aseptic conditions must be maintained. Before administration, the solution should be checked for discoloration or precipitates, and it should be stored in a cool, dry place out of reach of children. Furthermore, transferring the solution to a different container should be avoided as it can lead to deterioration and accidents.

Serious side effects

• Hypotension
• pulmonary edema
• jaundice
• reduced urine output
• coma
• vascular congestion
• shock peripheral vascular collapse
• bleeding and congestion in the lungs
• severe edema or urinary abnormalities
• severe skin reaction

Mild side effects

• Sweating
• blurred vision
• tachycardia
• hypothermia
• nausea
• vomiting
• diarrhea
• hair loss
• brittle nails
• dermatitis

This medication should be stored in a sealed container to prevent exposure to air, with a recommended storage temperature between 15 and 30 degrees Celsius. Proper storage will maintain the effectiveness of the medication and prevent degradation.

Appearance

A colorless, transparent vial injection containing an odorless, colorless, or slightly blue transparent liquid

Package unit

10mL/vial x 10